Salbutamol-Inteli inhalation under pressure, suspension 100 mcg/dose 200 doses 10 ml.

$11.00

Manufacturer: Spain

Purpose: Bronchodilator for asthma, relaxes muscles in airways to improve breathing.

SKU: MED61132 Categories: , ,

Description

Salbutamol-Inteli Inhalation Under Pressure, Suspension 100 mcg/dose 200 doses 10 ml

Ingredients:

Salbutamol sulfate, lactose monohydrate, norflurane, and oleic acid.

Dosage:

The usual dose is 1 to 2 inhalations every 4 to 6 hours as needed. Consult a healthcare professional for personalized recommendations.

Indications:

Salbutamol-Inteli Inhalation is indicated for the treatment of bronchospasm in conditions such as asthma and chronic obstructive pulmonary disease (COPD).

Contraindications:

Do not use Salbutamol-Inteli Inhalation if you are allergic to salbutamol or any of the other ingredients. It is important to inform your healthcare provider about any medical conditions or medications you are taking before using this product.

Directions:

– Shake the inhaler before each use.
– Breathe out gently, place the mouthpiece in your mouth, and inhale deeply.
– Hold your breath for a few seconds before exhaling slowly.
– Clean the mouthpiece regularly to prevent blockage.

Scientific Evidence:

Salbutamol, the active ingredient in Salbutamol-Inteli Inhalation, is a selective beta-2 adrenergic agonist that acts on the smooth muscles of the airways, leading to bronchodilation. Studies have shown the efficacy of salbutamol in relieving bronchospasm and improving airflow in patients with asthma and COPD (Source: Global Initiative for Asthma).

Additional Information:

Salbutamol-Inteli Inhalation provides quick relief from bronchospasm and is commonly used as a rescue inhaler for acute asthma attacks. It is important to follow the prescribed dosage and not exceed the recommended frequency of use to avoid potential side effects such as tremors or palpitations.

Pharmacologically, salbutamol works by stimulating beta-2 adrenergic receptors in the lungs, leading to relaxation of bronchial muscles and widening of the airways. This results in improved breathing capacity and relief from symptoms of bronchospasm.

Clinical trials have demonstrated the rapid onset of action of salbutamol, making it a preferred choice for the management of acute bronchospasm. Its effectiveness in dilating the airways and improving respiratory function has been well-documented in various studies, highlighting its role as a cornerstone therapy in the treatment of asthma and COPD.